Ryan Randolph

711 total citations
10 papers, 249 citations indexed

About

Ryan Randolph is a scholar working on Infectious Diseases, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Ryan Randolph has authored 10 papers receiving a total of 249 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 3 papers in Organic Chemistry and 3 papers in Molecular Biology. Recurrent topics in Ryan Randolph's work include HIV/AIDS drug development and treatment (3 papers), Synthesis and Biological Evaluation (3 papers) and Research on Leishmaniasis Studies (2 papers). Ryan Randolph is often cited by papers focused on HIV/AIDS drug development and treatment (3 papers), Synthesis and Biological Evaluation (3 papers) and Research on Leishmaniasis Studies (2 papers). Ryan Randolph collaborates with scholars based in United States, Switzerland and United Kingdom. Ryan Randolph's co-authors include Stephen A. Wring, John C. Cheronis, Danute Bankaitis‐Davis, Kendall D. Powell, Seonghee Park, George K. Abruzzo, David Angulo, Katyna Borroto–Esoda, Qing Chen and Amy Flattery and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Hepatology and Journal of Pharmaceutical Sciences.

In The Last Decade

Ryan Randolph

10 papers receiving 242 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryan Randolph United States 8 92 92 53 49 49 10 249
Lingaraja Jena India 12 105 1.1× 87 0.9× 34 0.6× 32 0.7× 41 0.8× 38 373
Aparecida Tiemi Nagao‐Dias Brazil 13 90 1.0× 138 1.5× 17 0.3× 38 0.8× 36 0.7× 33 406
Mitsuaki Hosoya Japan 8 74 0.8× 104 1.1× 22 0.4× 80 1.6× 52 1.1× 16 345
Yunzheng Yan China 9 107 1.2× 46 0.5× 26 0.5× 14 0.3× 21 0.4× 14 260
Elena Jiménez Spain 10 139 1.5× 127 1.4× 13 0.2× 24 0.5× 54 1.1× 11 333
Lizdany Flórez‐Álvarez Colombia 10 111 1.2× 38 0.4× 22 0.4× 92 1.9× 15 0.3× 23 307
Ajay Amit India 12 62 0.7× 127 1.4× 25 0.5× 85 1.7× 29 0.6× 22 390
Salman Ali Khan Pakistan 8 207 2.3× 34 0.4× 27 0.5× 26 0.5× 79 1.6× 24 422
Iqra Muneer China 7 130 1.4× 40 0.4× 12 0.2× 40 0.8× 54 1.1× 7 396
Petter I. Andersen Estonia 3 133 1.4× 48 0.5× 12 0.2× 21 0.4× 22 0.4× 3 274

Countries citing papers authored by Ryan Randolph

Since Specialization
Citations

This map shows the geographic impact of Ryan Randolph's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan Randolph with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan Randolph more than expected).

Fields of papers citing papers by Ryan Randolph

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan Randolph. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan Randolph. The network helps show where Ryan Randolph may publish in the future.

Co-authorship network of co-authors of Ryan Randolph

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan Randolph. A scholar is included among the top collaborators of Ryan Randolph based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan Randolph. Ryan Randolph is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Bocxlaer, Katrien Van, Eric Gaukel, Vanessa Yardley, et al.. (2018). Topical Treatment for Cutaneous Leishmaniasis: Dermato-Pharmacokinetic Lead Optimization of Benzoxaboroles. Antimicrobial Agents and Chemotherapy. 62(5). 29 indexed citations
2.
Wring, Stephen A., Ryan Randolph, Seonghee Park, et al.. (2017). Preclinical Pharmacokinetics and Pharmacodynamic Target of SCY-078, a First-in-Class Orally Active Antifungal Glucan Synthesis Inhibitor, in Murine Models of Disseminated Candidiasis. Antimicrobial Agents and Chemotherapy. 61(4). 75 indexed citations
3.
Moss, Darren, Paul L. Domanico, Seonghee Park, et al.. (2017). Simulating Intestinal Transporter and Enzyme Activity in a Physiologically Based Pharmacokinetic Model for Tenofovir Disoproxil Fumarate. Antimicrobial Agents and Chemotherapy. 61(7). 11 indexed citations
4.
Missler, Stephen R., Arun Rajgopal, Jeffrey D. Scholten, et al.. (2016). Synergistic Activation of the Nrf2-ARE Oxidative Stress Response Pathway by a Combination of Botanical Extracts. Planta Medica International Open. 3(2). e27–e30. 6 indexed citations
5.
Wring, Steve, et al.. (2016). Development of a Novel Formulation That Improves Preclinical Bioavailability of Tenofovir Disoproxil Fumarate. Journal of Pharmaceutical Sciences. 106(3). 906–919. 21 indexed citations
6.
Moore, Terry W., Shijun Zhu, Ryan Randolph, Mamoru Shoji, & James P. Snyder. (2014). Liver S9 Fraction-Derived Metabolites of Curcumin Analogue UBS109. ACS Medicinal Chemistry Letters. 5(4). 288–292. 16 indexed citations
8.
Freeman, Jennifer C., Cyrus J. Bacchi, Tana Bowling, et al.. (2011). SAR of 2-amino and 2,4-diamino pyrimidines with in vivo efficacy against Trypanosoma brucei. Bioorganic & Medicinal Chemistry Letters. 21(10). 2816–2819. 7 indexed citations
9.
Wring, Steve, et al.. (2010). 676 IN VITRO MODELS FOR ASSESSING THE RELATIVE RISK OF HYPERBILIRUBINEMIA ASSOCIATED WITH CYCLOPHILIN INHIBITOR THERAPY. Journal of Hepatology. 52. S263–S263. 5 indexed citations
10.
Randolph, Ryan, et al.. (2003). Regulation of Human Immune Gene Expression as Influenced by a Commercial Blended Echinacea Product: Preliminary Studies. Experimental Biology and Medicine. 228(9). 1051–1056. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026